CISPLATIN VERSUS CISPLATIN PLUS ETOPOSIDE IN THE TREATMENT OF ADVANCED NON SMALL-CELL LUNG-CANCER

被引：126

作者：

KLASTERSKY, J

SCULIER, JP

BUREAU, G

LIBERT, P

RAVEZ, P

VANDERMOTEN, G

THIRIAUX, J

LECOMTE, J

CORDIER, R

DABOUIS, G

BROHEE, D

THEMELIN, L

MOMMEN, P

机构：

来源：

关键词：

D O I：

10.1200/JCO.1989.7.8.1087

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1087 / 1092

页数：6

共 19 条

[1] AISNER J, 1981, CANCER TREAT REP, V65, P979
[2] IMPROVED APPROXIMATE FORMULA FOR CALCULATING SAMPLE SIZES FOR COMPARING 2 BINOMIAL DISTRIBUTIONS
CASAGRANDE, JT
PIKE, MC
SMITH, PG
[J]. BIOMETRICS, 1978, 34 (03) : 483 - 486
[3] COX DR, 1972, J R STAT SOC B, V34, P187
[4] DEJAGER R, 1980, CANCER TREAT REP, V64, P1341
[5] RANDOMIZED TRIAL OF 3 COMBINATIONS OF CISPLATIN WITH VINDESINE AND OR VP-16-213 IN THE TREATMENT OF ADVANCED NON SMALL-CELL LUNG-CANCER
DHINGRA, HM
VALDIVIESO, M
CARR, DT
CHIUTEN, DF
FARHA, P
MURPHY, WK
SPITZER, G
UMSAWASDI, T
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (02) : 176 - 183
[6] DURAND RE, 1987, CANCER TREAT REP, V71, P673
[7] EAGAN RT, 1977, CANCER TREAT REP, V61, P1339
[8] EINHORN LH, 1982, CANCER TREAT REP, V66, P2005
[9] VINDESINE AND CISPLATIN COMBINATION CHEMOTHERAPY COMPARED WITH VINDESINE AS A SINGLE AGENT IN THE MANAGEMENT OF NON-SMALL CELL LUNG-CANCER - A RANDOMIZED STUDY
ELLIOTT, JA
AHMEDZAI, S
HOLE, D
DORWARD, AJ
STEVENSON, RD
KAYE, SB
BANHAM, SW
STACK, BHR
CALMAN, KC
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (08): : 1025 - 1032
[10] PLANNING SIZE AND DURATION OF A CLINICAL TRIAL STUDYING TIME TO SOME CRITICAL EVENT
GEORGE, SL
DESU, MM
[J]. JOURNAL OF CHRONIC DISEASES, 1974, 27 (1-2): : 15 - 24